Insulin pump therapy, also known as CSII, is an important and evolving form of insulin delivery; it is used mainly for people with T1D who are motivated to improve glycaemic control [12,50] but many people with T2D are now also using pump therapy. The gene discussed is INS; the disease is type 2 diabetes mellitus.